Summary
(α1→3)-l-Fucosyltransferase activity was measured in serum samples from 90 gastric cancer patients, 10 patients with benign diseases and 100 healthy controls. The enzyme activity was significantly elevated in the serum samples of patients with cancer compared to those from patients with benign diseases (P<0.01) and healthy controls (P<0.001). The elevation of the enzyme activity was found to correlate strongly with the clinical stage of disease. The sensitivity of (α1→3)-l-fucosyltransferase was also demonstrated to be high in comparison with the tumor-associated antigens, such as carcinoembryonic antigen and sialylated Lewis X-i. Follow-up studies of (α1→3)-l-fucosyltransferase in 11 cancer patients with disease at different stages showed that the enzyme activity could be useful for monitoring the postsurgical course of the disease. These results suggest that (α1→3)-l-fucosyltransferase activity has a clinically important potential as a tumor marker in gastric cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- Gal:
-
d-galactose
- Fuc:
-
l-fucose
- GlcNAc:
-
N-acetyl-d-glucosamine
- HEPES:
-
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
References
Abbas SA, Piskarz CF, Matta KL (1987) Synthesis of 2-acetamido-2-deoxy-4-O-(2-O-methyl-β-d-galactopyranosyl)-d-glucopyranose (N-acetyl-2′-O-methyllactosamine). Carbohydr Res 167:131–141
Bauer CH, Köttgen E, Reutter W (1977) Elevated activities of α.2-and α-3-fucosyltransferases in human serum as a new indicator of malignancy. Biochem Biophys Res Common 76:488–494
Campbell C, Stanley P (1984) The Chinese hamster ovary glycosylation mutants LEC11 and LEC12 express two novel GDP-fucose: N-acetylglucosaminide 3-α-l-fucosyltransferase enzymes. J Biol Chem 259:11208–11214
Chia D, Terasaki PI, Suyama N, Galton J, Hirota M, Katz D (1985) Use of monoclonal antibodies to sialylated Lex and sialylated Lea for serological tests of cancer. Cancer Res 45:435–437
Davey RA, Milliken ST, Harvie RM, Cahill EJ, Morgan J, Kerestes Z, Levi JA (1986) Serum galactosyltransferase as a prognostic marker in patients with solid tumors. Cancer Res 46:5973–5975
Fukushi Y, Hakomori S, Shepard T (1984a) Localization and alteration of mono-, di-, and trifucosyl α1→3 type 2 chain structures during human embryogenesis and in human cancer. J Exp Med 159:506–520
Fukushi Y, Hakomori S, Nudelman E, Cochran N (1984b) Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J Biol Chem 259:4681–4685
Fukushi Y, Nudelman E, Levery SA, Rauvala H, Hakomori S (1984c) Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside VI3NeuAcV3III3Fuc2nLc6). J Biol Chem 259:10511–10517
Ganzinger U, Deutsch E (1980) Serum sialytransferase levels as a parameter in the diagnosis and follow-up of gastrointestinal tumors. Cancer Res 40:1300–1304
Gauduchon P, Tillier C, Guyonnet C, Heron JF, Bar-guilloux E, Le Talaer JY (1983) Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma. Cancer Res 43:4491–4496
Hakomori S, Nudelman E, Levery SB, Kannagi R (1984) Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di-or trifucosylated type 2 chain. J Biol Chem 259:4672–4680
Hermanek P, Sobin LH (eds) (1987) TNM Classification of Malignant Tumours, Springer, Berlin Heidelberg New York, pp 43–46
Hirota M, Fukushima K, Terasaki PI, Terashita GY, Kawahara M, Chia D, Suyama N, Togashi H (1985) Sialylated Lewisx in the sera of cancer patients detected by a cell-binding inhibition assay. Cancer Res 45:1901–1905
Holmes EH, Ostrander GK, Hakomori S (1985) Enzymatic basis for the accumulation of glycolipids with X and dimeric X determinants in human lung cancer cells (NCI-H69). J Biol Chem 260:7619–7627
Holmes EH, Ostrander GK, Hakomori S (1986) Biosynthesis of the sialyl-Lex determinant carried by type 2 chain glycosphingolipids (IV3NeuAcIII3FuncnLc4, VI3NeuAcV3FucnLc6, and VI3NeuAcIII3V3Fuc2nLc6) in human lung carcinoma PC9 cells. J Biol Chem 261:3737–3743
Horward DR, Fukuda M, Fukuda MN, Stanley P (1987) The GDP-fucose: N-acetylglucosaminide 3-α-l-fucosyltransferases of LEC11 and LEC12 Chinese hamster ovary mutants exhibit novel specificities for glycolipid substances. J Biol Chem 262:16830–16837
Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, Hiraiwa N, Fukuda Y, Inamoto T, Hakomori S, Imura H (1986) Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res 46:2619–2626
Kawahara M, Chia D, Terasaki PI, Roumanas A, Sugich L, Hermes M, Iguro T (1985) Detection of sialylated Lewisx antigen in cancer sera using a sandwich radioimmunoassay. Int J Cancer 36:421–425
Kessel D, Allen J (1975) Elevated plasma sialyltransferase in the cancer patient. Cancer Res 35:670–672
Madiyalakan R, Yazawa S, Abbas SA, Barlow JJ, Matta KL (1986a) Use of N-acetyl-2′-O-methyllactosamine as a specific acceptor for the determination of α-l-(1→3)-fucosyltransferase in human serum. Anal Biochem 152:22–28
Madiyalakan R, Yazawa S, Barlow JJ, Matta KL (1986b) Elevated serum α(1→3)-l-fucosyltransferase activity with synthetic low molecular weight acceptor in human ovarian cancer. Cancer Lett 30:201–205
Madiyalakan R, Yazawa S, Matta KL (1988) Characterization of plasma α(1→3)-l-fucosyltransferase from an ovarian cancer patient with the aid of synthetic substrates. Ind J Biochem Biophys 25:32–35
Magnani JL, Ball ED, Fanger MW, Hakomori S, Ginsburg V (1984) Monoclonal antibodies PMN6, PMN29, and PM-81 bind differently to glycolipids containing a sugar sequence occurring in lacto-N-fucopentaose III. Arch Biochem Biophys 233:501–506
Podolsky DK, Weiser MM (1975) Galactosyltransferase activities in human sera: detection of a cancer-associated isoenzyme. Biochem Biophys Res Commun 65:545–551
Sears HF, Herlyn M, Del Villano B, Steplewski Z, Koprowski H (1982) Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. J Clin Immunol 2:141–149
Tetteroo PA, De Heij HT, Van den Eijnden DH, Visser FJ, Schoenmaker E, Geurts Van Kessel AD HM (1987) A GDP-fucose: [Galβ1→4]GlcNAc α1→3-fucosyltransferase activity is correlated with the presence of human chromosome 11 and the expression of the LeX, LeY, and sialyl-LeX antigens in human mouse cell hybrids. J Biol Chem 262:15984–15989
Yang HJ, Hakomori S (1971) A sphingolipid having a novel type of ceramide and “lacto-N-fucopentaose III”. J Biol Chem 246:1192–1200
Yazawa S, Madiyalakan R, Piver MS, Matta KL (1986) Elevated activities of blood group Le gene dependent α(1→3)-l-fucosyltransferase in human saliva of Lewis negative patients with epithelial ovarian cancer. Cancer Lett 32:165–169
Yazawa S, Madiyalakan R, Izawa H, Asao T, Furukawa K, Matta KL (1988) Cancer-associated elevation of α(1→3)-l-fucosyl-transferase activity in human serum. Cancer 62:516–520
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yazawa, S., Asao, T., Nagamachi, Y. et al. Tumor-related elevation of serum (α1→3)-l-Fucosyltransferase activity in gastric cancer. J Cancer Res Clin Oncol 115, 451–455 (1989). https://doi.org/10.1007/BF00393336
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00393336